AZAD continually invests into further development and expansion of its API portfolios. Process research on new APIs is performed under the supervision of AZAD’s chemists based in Switzerland, at our R&D labs in Armenia, allowing cost-effective development of innovative chemistry and polymorphic forms of APIs, that are then patent-protected. In addition, using the above facility and expertise, AZAD offers contract R&D for 3rd parties interested in synthetic route development of specific APIs.
Product | Indication | Remark |
---|---|---|
Bilastine | Antihistamine | |
Ferric Carboxymaltose | Iron deficiency | Produced in Switzerland |
Nelarabine | Leukemia | |
Tafamidis | ATTR-Amyloidose (CM and PN) | New polymorph; produced in Switzerland |
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.